Search Ontology:
ChEBI
ceftriaxone
- Term ID
- CHEBI:29007
- Synonyms
-
- (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- 7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic acid
- ceftriaxona
- ceftriaxone
- ceftriaxonum
- rocephin
- Definition
- A third-generation cephalosporin compound having 2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetylamino and [(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl side-groups.
- References
-
- CAS:73384-59-5
- DrugBank:DB01212
- Drug_Central:564
- HMDB:HMDB0015343
- KEGG:C06683
- KEGG:D07659
- MetaCyc:CPD-12294
- PMID:11067716
- PMID:11285492
- PMID:11431418
- PMID:11432680
- PMID:11529382
- PMID:11605716
- PMID:11642230
- PMID:11760218
- PMID:11815759
- PMID:11856984
- PMID:11875753
- PMID:11985490
- PMID:12146884
- PMID:12426628
- PMID:12569987
- PMID:12711894
- PMID:12797390
- PMID:12830336
- PMID:12833570
- PMID:12868545
- PMID:1384868
- PMID:15091234
- PMID:15106316
- PMID:15225244
- PMID:15499067
- PMID:15828439
- PMID:15846537
- PMID:15880392
- PMID:15886468
- PMID:16082406
- PMID:16118675
- PMID:16161754
- PMID:16185184
- PMID:16602117
- PMID:16640341
- PMID:16734965
- PMID:17129840
- PMID:17173674
- PMID:17216959
- PMID:17226043
- PMID:17347554
- PMID:17367972
- PMID:17592517
- PMID:18246742
- PMID:18473104
- PMID:18484523
- PMID:18611641
- PMID:18676229
- PMID:18773080
- PMID:18977704
- PMID:19008722
- PMID:19367098
- PMID:19423473
- PMID:19496200
- PMID:19625514
- PMID:19649758
- PMID:21425867
- PMID:29017833
- Patent:GB2022090
- Patent:US4327210
- Reaxys:6495519
- Wikipedia:Ceftriaxone
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
- is a type of
-
- has_role
-
- inverse is_conjugate_base_of
-
- is_conjugate_acid_of
-
Phenotype
Phenotype resulting from ceftriaxone
Phenotype where environments contain ceftriaxone
Phenotype modified by environments containing ceftriaxone
Human Disease Model